Premium Nahrungsergänzungsmittel | artgerecht

Staphylococcus aureus – Infection, MRSA & Treatment

Staphylococcus aureus is a gram-positive bacterium and one of the most common causes of skin, wound, and respiratory infections. Resistant strains such as MRSA pose a serious public health challenge.

Regular tips about health Regular tips about health

Things worth knowing about "Staphylococcus aureus"

Staphylococcus aureus is a gram-positive bacterium and one of the most common causes of skin, wound, and respiratory infections. Resistant strains such as MRSA pose a serious public health challenge.

What is Staphylococcus aureus?

Staphylococcus aureus (abbreviated S. aureus) is a spherical, gram-positive bacterium belonging to the Staphylococcaceae family. It is one of the most significant bacterial pathogens in humans and naturally colonises the skin and mucous membranes of the nose and throat. Approximately 20–30% of the general population carry S. aureus without developing any symptoms (asymptomatic colonisation).

Causes and Transmission

S. aureus is primarily transmitted through direct contact with infected individuals or contaminated surfaces. It poses a particular risk in hospital and care settings. Common routes of transmission include:

Direct skin-to-skin contact with carriers or infected individuals
Contact with contaminated objects or surfaces (contact transmission)
Droplet transmission via coughing or sneezing
Contaminated food containing staphylococcal enterotoxins

Symptoms and Clinical Manifestations

S. aureus can cause a wide spectrum of infections, ranging from minor skin conditions to life-threatening systemic illness:

Skin infections: Furuncles, carbuncles, impetigo, and wound infections
Respiratory infections: Pneumonia, especially following influenza
Bone infections: Osteomyelitis
Heart valve infection: Endocarditis
Bloodstream infection: Sepsis – a potentially fatal systemic condition
Toxic Shock Syndrome (TSS): Caused by staphylococcal toxins, presenting with high fever, shock, and organ failure
Food poisoning: Resulting from preformed toxins in contaminated food

Diagnosis

Diagnosis of S. aureus infection is primarily made through microbiological testing. Swabs, blood, urine, or wound samples are analysed in a laboratory. Common diagnostic methods include:

Bacterial culture: Growing the organism on culture media for definitive identification
Gram staining: Microscopic examination for initial classification
PCR testing: Molecular rapid detection, particularly used for MRSA screening
Antibiogram: Assessment of antibiotic sensitivity to guide treatment decisions

Treatment

Treatment depends on the type and severity of the infection and the antibiotic susceptibility of the identified strain:

Penicillinase-resistant penicillins (e.g., flucloxacillin) are the first-line treatment for susceptible S. aureus strains.
First-generation cephalosporins may be used as an alternative.
For MRSA (Methicillin-resistant S. aureus), reserve antibiotics such as vancomycin, linezolid, or daptomycin are required.
Local skin and wound infections may also require surgical intervention, such as incision and drainage of abscesses.

MRSA – Methicillin-Resistant Staphylococcus aureus

MRSA refers to strains of S. aureus that have developed resistance to most commonly used antibiotics. MRSA infections are particularly dangerous and are classified as hospital-acquired (HA-MRSA) or community-acquired (CA-MRSA). Strict hygiene protocols and systematic screening programmes are essential for controlling its spread.

Prevention

The following measures are recommended to reduce the risk of S. aureus infection:

Regular and thorough handwashing with soap and water
Proper wound disinfection and care
Adherence to hygiene guidelines in healthcare settings
Avoiding sharing personal items such as towels or razors
Safe food handling, preparation, and storage practices

References

Lowy FD. Staphylococcus aureus infections. New England Journal of Medicine. 1998;339(8):520–532. DOI: 10.1056/NEJM199808203390806
World Health Organization (WHO): Antimicrobial Resistance – Global Action Plan. Geneva, 2015. Available at: www.who.int
Tong SYC, Davis JS, Eichenberger E, Holland TL, Fowler VG Jr. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clinical Microbiology Reviews. 2015;28(3):603–661. DOI: 10.1128/CMR.00134-14

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.